Monoclonal antibody against influenza A viruses (Crucell)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameMonoclonal antibody against influenza A viruses (Crucell)
Drug Alias NameInfluenza monoclonal antibody 40C7ๆŠ—็”ฒๅž‹ๆตๆ„Ÿ็—…ๆฏ’ๅ•ๅ…‹้š†ๆŠ—ไฝ“ - CrucellAๅž‹ๆตๆ„Ÿ็—…ๆฏ’ๅ•ๅ…‹้š†ๆŠ—ไฝ“ - CrucellAnti Flu Virus mAb40C7CR-8020 +[6]ย 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAimm Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutical KkCrucell Holland Bv
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A